The chart below shows how ZTS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ZTS sees a +2.42% change in stock price 10 days leading up to the earnings, and a +1.87% change 10 days following the report. On the earnings day itself, the stock moves by -0.48%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Revenue and Income Growth: Revenue grew 14% operationally and adjusted net income is up 15% operationally.
Revenue Growth Analysis: U.S. revenue grew 15% and international revenue grew 13% operationally.
Companion and Livestock Growth: Our innovative companion animal portfolio grew 15% operationally, while livestock grew 11% on an operational basis.
Diverse Portfolio Growth: Our consistent growth is fueled by a diverse, durable, and science-driven portfolio, carefully crafted through a deep understanding of our customers' evolving needs.
Simparica Franchise Growth: Our Simparica franchise continues to deliver impressive results, growing 27% operationally.
Negative
Revenue Growth Slowdown: Revenue growth was only 11% on a reported basis, which is a significant slowdown compared to previous quarters.
Profitability Growth Decline: Adjusted net income of $716 million grew only 14% on a reported basis, indicating a decline in profitability growth rate.
Operating Expenses Increase: Adjusted operating expenses increased by 9% operationally, which could pressure future margins.
Sales Decline Impact: The company faced a reduction in sales for the divestiture of its Medicated Feed Additive product, impacting overall revenue.
Revenue Growth Slowdown: There are expectations of a slowdown in revenue growth rates for Q4, reflecting challenges in maintaining momentum.
Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
ZTS.N
2.62%